Stay updated with breaking news from Expenses General. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
10.08.2023 - Successful End-of-Phase 2 meeting with FDA regarding AL102 for the treatment of desmoid tumors Enrollment in the Phase 3 segment of RINGSIDE trial evaluating AL102 continuing globally as planned Definitive merger agreement with Biosight, expected ...
REHOVOT, Israel and MONMOUTH JUNCTION, N.J., May 23, 2023 -- Ayala Pharmaceuticals, Inc. , a clinical-stage oncology company, today announced first-quarter 2023 financial results and provided a... | May 23, 2023
REHOVOT, Israel and MONMOUTH JUNCTION, N.J., May 23, 2023 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology...
This management's discussion and analysis of the financial condition and results of operations of Planet 13 is for the years ended December 31, 2022 and 2021. It is supplemental to, and should be... | March 23, 2023
FORWARD LOOKING STATEMENTS This Management's Discussion and Analysis of Financial Condition and Results of Operations and other parts of this quarterly report contain forward-looking statements that... | August 22, 2022